FDA Approves New Parenteral Nutrition Therapy
B. Braun Medical Inc. announced that the FDA has approved Nutrilipid 20% (IV fat emulsion) for parenteral nutrition therapy in adult and pediatric patients.
Nutrilipid is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids due to a deficiency when oral or enteral nutrition is not possible, insufficient, or contraindicated. The FDA approval of Nutrilipid 20% will also help relieve the shortage of lipid emulsion products over the past two years.
Nutrilipid 20% will be available in flexible containers that are DEHP-, PVC-, and rubber latex-free. B. Braun Medical plans to launch Nutrilipid 20% soon.
For more information call (800) 227-2862 or visit BBraunUSA.com.